Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Levocetirizine dihydrochloride

Levocetirizine dihydrochloride

pharmaceutical raw materials
Levocetirizine dihydrochloride structure

Levocetirizine dihydrochloride 

structure
  • CAS No:

    130018-87-0

  • Formula:

    C21H25ClN2O3.2ClH

  • Chemical Name:

    Levocetirizine dihydrochloride

  • Synonyms:

    Acetic acid,2-[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-,hydrochloride (1:2);Acetic acid,[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-,dihydrochloride,(R)-;Acetic acid,[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-,dihydrochloride;Levocetirizine dihydrochloride;Xusal;Xyzal;Xyzall;UCB 28556;(R)-Cetirizine dihydrochloride;(R)-(-)-Cetirizine hydrochloride;Allercet;Lezyncet;Allear

  • Categories:

    Active Pharmaceutical Ingredients  >  Other Chemical Drugs

Description

Levocetirizine dihydrochloride,(R)-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl] ethoxy] acetic acid dihydrochloride, (Xyzal) is awhite, crystalline powder and is water soluble. ThisR-enantiomer is has a 30-fold higher affinity than the S-enantiomer,and dissociates more slowly from H1-receptors.Pharmacologically, it displays the same receptor and CNSselecitivity profile as the racemate, cetirizine,and thus the same therapeutic advantages.

Levocetirizine dihydrochloride Basic Attributes

461.81

460.108734

200-659-6

W69HSF2416

DTXSID60231691

29335990

Characteristics

53

4.62800

white or off-white crystalline powder

215-220°C

542.1°C at 760 mmHg

281.6ºC

H2O: ≥23mg/mL

room temp

D25 -12.79° (c = 1 in water)

Safety Information

UN 3077 9 / PGIII

3

22-50/53

60-61

AG0990000

Xn,N

P273

H302-H400

Drug Information

A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)

(2-(4-((R)-(4-chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride

Levocetirizine dihydrochloride Use and Manufacturing

Uses

Anti Histaminic

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:425.3
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:8
Exact Mass:424.1320481
Monoisotopic Mass:424.1320481
Topological Polar Surface Area:53
Heavy Atom Count:28
Complexity:443
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Antihistamine effect

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • SYMED LABS LTD

    United States United States
    Active
  • Chongqing Shengkai Pharmaceutical Co., Ltd.

    China China
    Active
  • Zhejiang Qianyuan Haili Sheng Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Levocetirizine dihydrochloride

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.